Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454402
Status:
TERMINATED
Last Update Posted:
2007-09-24
First Post:
2007-03-29
Brief Title:
ALF-STONE Alfuzosin in Uretheric Stones
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Alfuzosin in Uretheric Stones
Status:
TERMINATED
Status Verified Date:
2007-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Discontinued due to incomplete recruitment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to assess the effect of Alfuzosin compared with placebo for 7 days on the outcome of patients with uretheric stones submitted to Extracorporeal Shock Wave Lithotripsy ESWL namely in the percentage of patients without imagiologic evidence of any stone after 72h to 96 hours
This study will also specifically focus on the evaluation of time of stone clearance and of pain reduction Numeric Rating Scale
This study will also specifically focus on the evaluation of time of stone clearance and of pain reduction Numeric Rating Scale
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2005-005481-36 | None | None | None |